Evidence map›Paper›PMID 40957939›Full record

ArticleJournal of bone and mineral metabolism2025

Comment on "Probability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis".

Caroline Francis, Koyel Roy, Gujar Anantkumar Jotiram

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of bone and mineral metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Caroline FrancisTrauma and Orthopedics, Royal Infirmary, Hull, UK.
Koyel RoySchool of Law, Arka Jain University, Jamshedpur, Jharkhand, 832108, India. koyelroy847@gmail.com.ORCID http://orcid.org/0009-0007-1085-6928
Gujar Anantkumar JotiramJaywant College of Engineering and Polytechnic, Kille Machhindragad, Tal. Walwa, Sangli, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This commentary evaluates the study by Takada et al. on sequential teriparatide bisphosphonate therapy in postmenopausal osteoporosis. While lumbar spine bone mineral density (BMD) targets are frequently met, the clinical validity of total hip BMD thresholds, especially in Asian populations, remains uncertain. We emphasize the need for fracture-based endpoints and caution against over-reliance on surrogate BMD targets in pre-treated patients.

Indexed as

Bone Density Conservation AgentsDiphosphonatesOsteoporosis, PostmenopausalTeriparatideBone DensityEast Asian PeopleFemaleHumansJapanBone Density Conservation AgentsDiphosphonatesTeriparatide

Identifiers

PMID40957939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.